As we step into a new year, here’s a recap of key highlights from 2024 in the field of biomarkers at Staburo.
June: At the PSI conference in Amsterdam, biomarkers were the focus of a dedicated session, followed by an in-person meeting of the PSI/EFSPI Biomarker SIG.
August: Our team connected and collaborated during a productive and enjoyable team event at Kletterwald.
November: We presented Deep Learning in Image Analysis in the Machine Learning Substream of the PSI/EFSPI Biomarker SIG, showcasing advancements in the field of machine learning and biomarkers.
November: At the APF event, we met old friends, built new relationships and strengthened long-term collaborations in biomarker research.
Looking ahead, we’re excited to continue working in the field of biomarkers and early clinical development on meaningful projects and further strengthening our collaborations in 2025. We’re also looking forward to the PSI conference in London this June, where we plan to reconnect with the PSI/EFSPI Biomarker SIG and engage with thought-provoking sessions.
Biomarkers remain a key focus for advancing healthcare and research, and we’re proud to be part of this evolving field.
For more information on biomarkers and our services, check out our page and click here.
